We turn data into actionable clinical knowledge
Massachusetts General Hospital (MGH) Biostatistics includes over 50 faculty and staff who are deeply embedded in collaborative statistical methods and applied biomedical research. We work in diverse domains across over 25 Divisions and Departments at MGH and beyond. Our mission is to engage in impactful trans-disciplinary collaborations involving quantitative methods in public health and biomedicine.
News & Events
Dr. Tanayott Thaweethai, Dr. Andrea S. Foulkes, and other members of MGH Biostatistics lead a JAMA paper defining long COVID
Tanayott Thaweethai, PhD, and Andrea S. Foulkes, ScD, alongside several other members of MGH Biostatistics including co-authors Caitlin A. Selvaggi, MS, Daniel J. Shinnick, MS, and Carolin Schulte, PhD, led a manuscript titled, “Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection,” published online in the Journal of the American Medical Association (JAMA) on May 25, 2023. This is a significant launching point for future research into understanding risk factors, mechanisms of disease, and potential therapies for long COVID.
Applied Biostatistics Seminar Series on Tue May 9: Does Real-World Evidence have a role in Precision Oncology?
Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to clinical
Applied Biostatistics Seminar Series on Thu Apr 20: Moving to a World Beyond p<0.05
Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to clinical
Applied Biostatistics Seminar Series on Thu Dec 1: Using stochastic-interventional causal effects to evaluate treatment efficacy in clinical trials (Nima Hejazi, PhD)
Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to clinical
MGH Biostatistics Launches Faculty Search 2022
The Massachusetts General Hospital (MGH) Division of Clinical Research is seeking qualified applicants with doctoral degrees in Biostatistics or a related field for a faculty-level position in Biostatistics.
Dr. Andrea Foulkes to Receive 2022 Lagakos Distinguished Alumni Award
Andrea S. Foulkes, ScD, director of Biostatistics at MGH, will be the recipient of the 2022 Lagakos Distinguished Alumni Award from the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. This award recognizes Department alumni whose research in statistical theory and application, leadership in biomedical research, and commitment to teaching have had a major impact on the theory and practice of statistical science.
Mass General Brigham investigators approved for large studies on reversing acute suicidal depressed state, bipolar depression
A research team at MGH, led by Andrew A. Nierenberg, MD, director of the Dauten Family Center for Bipolar Treatment Innovation, and Andrea S. Foulkes, ScD, director of Biostatistics, has been approved for nearly $25 million in funding by the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of four treatments for bipolar depression.
Applied Biostatistics Seminar Series on Wed Jul 27: Opportunities and Challenges in Using Digital Biomarkers as Trial Outcomes and Enrichment (Hiroko Dodge, PhD)
Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a new seminar series designed to introduce researchers to intermediate topics that are highly relevant to
Inaugural MGH Biostatistics Student Research Symposium
This semester, we were very lucky to have the following students from the biostatistics department at Harvard T.H. Chan School of Public Health join us in several different collaborative and
Applied Biostatistics Seminar Series on Thu May 19: The essential role of early phase clinical trials in oncology (Alexia Iasonos, PhD)
Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a new seminar series designed to introduce researchers to intermediate topics that are highly relevant to
